Shailender Bhatia, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    Regeneron
    Date added:
    02/28/2025
    Date updated:
    03/01/2025

Pages

Return to Optimizing Immuno-Oncology: Innovations in Immune Checkpoint Inhibitor Delivery